These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 7653432

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Gastric emptying in gastroesophageal reflux and the therapeutic role of prokinetic agents.
    McCallum RW.
    Gastroenterol Clin North Am; 1990 Sep; 19(3):551-64. PubMed ID: 1977702
    [Abstract] [Full Text] [Related]

  • 3. Prokinetic agents: a key in the future of gastroenterology.
    Reynolds JC.
    Gastroenterol Clin North Am; 1989 Jun; 18(2):437-57. PubMed ID: 2668178
    [Abstract] [Full Text] [Related]

  • 4. The current status of gastric prokinetic drugs.
    Schapira M, Henrion J, Heller FR.
    Acta Gastroenterol Belg; 1990 Jun; 53(4):446-57. PubMed ID: 1982914
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Pharmacologic and clinical differentiation of prokinetic drugs].
    May B, Greving I.
    Leber Magen Darm; 1996 Jul; 26(4):193-8. PubMed ID: 8965601
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prokinetic drug therapy in children: a review of current options.
    Chicella MF, Batres LA, Heesters MS, Dice JE.
    Ann Pharmacother; 2005 Apr; 39(4):706-11. PubMed ID: 15755792
    [Abstract] [Full Text] [Related]

  • 11. Clinical considerations in GERD (gastroesophageal reflux disease) therapy: focus on cisapride.
    Snape WJ.
    Am J Manag Care; 1997 May; 3(5):766-71. PubMed ID: 10184748
    [Abstract] [Full Text] [Related]

  • 12. Prokinetic agents in postgastrectomy patients.
    Patterson DJ.
    Gastroenterol Clin North Am; 1994 Jun; 23(2):313-25. PubMed ID: 7915253
    [Abstract] [Full Text] [Related]

  • 13. Domperidone, metoclopramide, and placebo. All give symptomatic improvement in gastroesophageal reflux.
    Maddern GJ, Kiroff GK, Leppard PI, Jamieson GG.
    J Clin Gastroenterol; 1986 Apr; 8(2):135-40. PubMed ID: 3745846
    [Abstract] [Full Text] [Related]

  • 14. Review article: promotility drugs in the treatment of gastro-oesophageal reflux disease.
    Ramirez B, Richter JE.
    Aliment Pharmacol Ther; 1993 Feb; 7(1):5-20. PubMed ID: 8094981
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Use of metoclopramide, domperidone, and cisapride in the management of diabetic gastroparesis.
    Brown CK, Khanderia U.
    Clin Pharm; 1990 May; 9(5):357-65. PubMed ID: 2190745
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Drug therapy of reflux oesophagitis: an update.
    Tytgat GN.
    Scand J Gastroenterol Suppl; 1989 May; 168():38-49. PubMed ID: 2575792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.